Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma

Bibliographic Details
Main Authors: Andrew Patterson, Noam Auslander
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-41662-3
_version_ 1797558059239735296
author Andrew Patterson
Noam Auslander
author_facet Andrew Patterson
Noam Auslander
author_sort Andrew Patterson
collection DOAJ
first_indexed 2024-03-10T17:25:05Z
format Article
id doaj.art-259751ba3ff64b7dae89d4ba26b02d7f
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-10T17:25:05Z
publishDate 2023-09-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-259751ba3ff64b7dae89d4ba26b02d7f2023-11-20T10:11:57ZengNature PortfolioNature Communications2041-17232023-09-011411110.1038/s41467-023-41662-3Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanomaAndrew Patterson0Noam Auslander1Genomics and Computational Biology Graduate Group, University of Pennsylvania - Perelman School of MedicineProgram in Molecular and Cellular Oncogenesis, The Wistar Institutehttps://doi.org/10.1038/s41467-023-41662-3
spellingShingle Andrew Patterson
Noam Auslander
Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
Nature Communications
title Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
title_full Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
title_fullStr Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
title_full_unstemmed Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
title_short Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
title_sort author correction mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
url https://doi.org/10.1038/s41467-023-41662-3
work_keys_str_mv AT andrewpatterson authorcorrectionmutatedprocessespredictimmunecheckpointinhibitortherapybenefitinmetastaticmelanoma
AT noamauslander authorcorrectionmutatedprocessespredictimmunecheckpointinhibitortherapybenefitinmetastaticmelanoma